Product
Pariet
1 clinical trial
1 indication
Indication
Peptic UlcerClinical trial
A Post-marketing Surveillance of Pariet Tab. 5 mg to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin, 100 mg or Less Daily, Administration in Korean Patients With a History of Gastric and Duodenal UlcerStatus: Completed, Estimated PCD: 2022-09-22